Leap Therapeutics
LPTX
LPTX
22 hedge funds and large institutions have $4.42M invested in Leap Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $4.66M → $4.42M (-$245K)
Holders
22
Holding in Top 10
–
Calls
$602K
Puts
–
Top Buyers
| 1 | +$1.15M | |
| 2 | +$137K | |
| 3 | +$90K | |
| 4 |
Bank of New York Mellon
New York
|
+$44.9K |
| 5 |
VF
Virtu Financial
New York
|
+$28K |
Top Sellers
| 1 | -$96K | |
| 2 | -$72.1K | |
| 3 | -$2.16K | |
| 4 |
LC
Lindbrook Capital
Calabasas,
California
|
-$2K |